Subscribe to Pharmaceutical Processing News

The Lead

Unfavorable FDA Vote on BioMarin's Drug

November 25, 2015 | by Matthew Dennis, FirstWord Pharma | Comments

BioMarin receives unfavorable FDA panel vote on Duchenne muscular dystrophy drug.


Reducing COPD: Novartis vs. GSK's Inhaler

November 25, 2015 10:15 am | by FDAnews Drug Daily Bulletin | Comments

Novartis’ once-daily inhaler tops GSK’s inhaler in reducing COPD.


Expanded Indication for Vertex's Cystic Fibrosis Drug

November 25, 2015 10:08 am | by FDAnews Drug Daily Bulletin | Comments

Vertex Pharma gets expanded indication for cystic fibrosis treatment from the EC.


NICE Declines Amgen & Roche Drugs

November 25, 2015 10:02 am | by FDAnews Drug Daily Bulletin | Comments

The NICE says it will not recommend these drugs. 


Merck KGaA & Pfizer Receive Designation for Drug

November 25, 2015 9:52 am | by FDAnews Drug Daily Bulletin | Comments

FDA awards Merck KGaA and Pfizer breakthrough therapy designation for metastatic Merkel cell carcinoma treatment. 


Accurate New Alternative to Animal Testing of Pharmaceuticals

November 24, 2015 1:53 pm | by UCF Business Incubation Program | Comments

Hesperos scientists awarded international prize for accurate new alternative to animal testing of pharmaceuticals.


Gaucher Disease Treatment Market: To Reach $1.16 Billion by 2024

November 24, 2015 1:42 pm | by GlobalData | Comments

Global Gaucher disease treatment market value will reach $1.16 billion by 2024, says GlobalData.


Bioinformatics Market to Grow from 2014 to 2020

November 24, 2015 10:25 am | by Marketwired | Comments

Bioinformatics market to grow at CAGR of 21.2% from 2014 to 2020, according to Grand View Research, Inc.


Brickell Biotech Secures Rights to Inhibitors for Psoriasis

November 24, 2015 10:18 am | by Business Wire | Comments

Brickell Biotech secures exclusive world-wide rights to a novel class of RORγ inhibitors for psoriasis and other autoimmune diseases.


BioIT Solution Brings Personalized Medicine to Cancer Patients

November 24, 2015 10:09 am | by Business Wire | Comments

MediSapiens Ltd introduces BioIT solution that brings personalized medicine to treatment of cancer patients at the Helsinki University Central Hospital.


First U.S. Patent for IBS-C Candidate

November 24, 2015 9:58 am | by PR Newswire | Comments

Issuance of first U.S. patent directly covering Synthetic Biologics' novel candidate for irritable bowel syndrome with constipation (IBS-C).


Salient CRGT to Provide IT Services to the FDA CVM

November 24, 2015 9:43 am | by PR Newswire | Comments

Salient CRGT awarded $15 million prime contract to provide IT services to the FDA Center for Veterinary Medicine.


Genentech Exercises Option for Ophthotech’s Drug

November 24, 2015 9:31 am | by FDAnews Drug Daily Bulletin | Comments

Roche’s Genentech exercises option for Ophthotech’s muscular degeneration drug.


Coming Soon to Big Pharma: Disruption Innovation

November 24, 2015 9:19 am | by Pharma Integrates | Comments

The changing pharmaceutical industry needs diversity, new thinking, and multi-sector experience, according to discussions at Pharma Integrates 2015.


Type 1 Diabetes Market: To Exceed $7 Billion by 2021

November 24, 2015 8:57 am | by GBI Research | Comments

Global type 1 diabetes mellitus market value will exceed $7 billion by 2021, says GBI Research.


FDA Approves Drug for Prophylaxis of DVT & PE After Surgery

November 23, 2015 10:43 am | by PR Newswire | Comments

The FDA approves Boehringer Ingelheim's drug for the prophylaxis of DVT and PE in patients who have undergone hip-replacement surgery.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.